Castleark Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.2M Buy
+118,690
New +$16.4M 0.45% 44
2020
Q1
– Sell
-245,798
Closed -$21.3M – 374
2019
Q4
$21.3M Sell
245,798
-8,269
-3% -$679K 0.85% 33
2019
Q3
$20.4M Sell
254,067
-295,268
-54% -$23.7M 0.83% 27
2019
Q2
$44M Sell
549,335
-9,625
-2% -$737K 1.69% 5
2019
Q1
$44.4M Buy
558,960
+239,852
+75% +$17.9M 1.67% 6
2018
Q4
$23.3M Buy
+319,108
New +$22.5M 0.99% 25
2015
Q3
– Sell
-374,450
Closed -$20.3M – 391
2015
Q2
$20.3M Sell
374,450
-216,046
-37% -$12.1M 0.54% 46
2015
Q1
$32.4M Buy
590,496
+279,785
+90% +$15.8M 0.78% 33
2014
Q4
$16.8M Buy
+310,711
New +$17.3M 0.43% 55
2013
Q4
– Sell
-255,628
Closed -$14.5M – 358
2013
Q3
$14.5M Buy
+255,628
New +$11.7M 0.41% 51

Other funds holding MRK

Castleark Management's MRK Position: Q3 2026 in Review

Castleark Management opened a new position in Merck (MRK) in Q3 2026: 118,690 shares worth $17.2M. The stake represents 0.45% of the portfolio and ranks #44 among its holdings. This is a return to the name: Castleark Management previously reported a position in MRK as recently as Q4 2019.

Castleark Management first reported a position in MRK in Q3 2013 and has held it in 10 quarters since. The position peaked at $44.4M in Q1 2019. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Castleark Management held 118,690 shares of Merck worth $17.2M as of Q3 2026.
  • Merck was a new Castleark Management position in Q3 2026.
  • Merck made up 0.45% of Castleark Management's portfolio in Q3 2026, its #44 holding.
  • Castleark Management first reported a position in Merck in Q3 2013 and has held it in 10 quarters since.
  • Castleark Management's Merck position peaked at $44.4M in Q1 2019.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.